Understanding the experience, treatment preferences and goals of people living with chronic lymphocytic leukemia (CLL) in Australia
Fifer, Simon, Godsell, Jenni, Opat, Stephen, Hamad, Nada, Lasica, Masa, Forsyth, Cecily, Morand, Louisa, Smeaton, Erica, Winton, Sharon, Puig, Andrea, McGeachie, Marija
Published in BMC cancer (11.07.2024)
Published in BMC cancer (11.07.2024)
Get full text
Journal Article
Australian data on the utilisation and duration on treatment of ibrutinib with a proton pump inhibitor in patients with relapsed or refractory chronic lymphocytic leukaemia
Salvaris, Ross, Mulligan, Stephen, Puig, Andrea, McGeachie, Marija, Opat, Stephen
Published in Internal medicine journal (01.11.2023)
Published in Internal medicine journal (01.11.2023)
Get full text
Journal Article
Ibrutinib use, treatment duration, and concomitant medications in Australian patients with relapsed or refractory chronic lymphocytic leukaemia
Mulligan, Stephen P., Opat, Stephen, Marlton, Paula, Kuss, Bryone, Gerungan, Poppy, Puig, Andrea, McGeachie, Marija, Tam, Constantine S.
Published in British journal of haematology (01.08.2022)
Published in British journal of haematology (01.08.2022)
Get full text
Journal Article
Real-world experience of Australian and New Zealand patients with chronic lymphocytic leukemia and mantle cell lymphoma accessing ibrutinib through a Named Patient Program
Mulligan, Stephen P., Opat, Stephen, Cheah, Chan Y., Kuss, Bryone, Hertzberg, Mark, Marlton, Paula, Poplar, Sarah, Puig, Andrea, McGeachie, Marija, Weinkove, Robert, Tam, Constantine S.
Published in Leukemia & lymphoma (28.01.2023)
Published in Leukemia & lymphoma (28.01.2023)
Get full text
Journal Article